Ambrx Biopharma Inc. Reports Full Year 2021 Financial Results; Provides Corporate Update

Retrieved on: 2022-04-26 20:20:55

Tags for this article:

Click the tags to see associated articles and topics

Ambrx Biopharma Inc. Reports Full Year 2021 Financial Results; Provides Corporate Update. View article details on hiswai:

Excerpt

SAN DIEGO--(BUSINESS WIRE)--Apr 26, 2022--. Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company using an ...

Article found on: www.bdtonline.com